BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9413887)

  • 1. Glucocorticoid-induced osteoporosis: novel approaches.
    Orcel P
    Rev Rhum Engl Ed; 1997 Nov; 64(11):629-37. PubMed ID: 9413887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of glucocorticoid osteoporosis (part II)].
    Nasonov EL; Skripnikova IA
    Klin Med (Mosk); 1997; 75(11):14-9. PubMed ID: 9490349
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucocorticoid-induced osteoporosis in inflammatory bowel disease.
    Lidofsky S; Smith J
    Med Health R I; 2009 Apr; 92(4):128-30. PubMed ID: 19452756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of glucocorticoid-induced osteoporosis.
    Cohen D; Adachi JD
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):337-49. PubMed ID: 15145443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucocorticoid induced osteoporosis].
    Lange U; Müller-Ladner U
    Orthopade; 2007 Apr; 36(4):381-8; quiz 389-90. PubMed ID: 17665509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In whom and how to prevent glucocorticoid-induced osteoporosis.
    Adachi JD; Papaioannou A
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to end steroid-induced fractures.
    Reid IR
    Arch Dermatol; 2001 Apr; 137(4):493-4. PubMed ID: 11295932
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blalock SJ; Norton LL; Patel RA; Dooley MA
    Arthritis Rheum; 2005 Oct; 53(5):732-9. PubMed ID: 16208664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment].
    Vestergaard P; Laursen LC; Schwarz P; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):898-900. PubMed ID: 15789844
    [No Abstract]   [Full Text] [Related]  

  • 14. [New data on the pathogenesis of steroid-induced osteoporosis: consequences for therapy and prevention].
    Hüfner M; Siggelkow H
    Dtsch Med Wochenschr; 2003 Jul; 128(30):1602-8. PubMed ID: 12884149
    [No Abstract]   [Full Text] [Related]  

  • 15. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM; Hillner BE
    J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical prophylaxis and treatment of steroid induced osteoporosis].
    Rødevand E; Mikkelsen K; Nordvåg BY; Haga HJ; Førre Ø; Johnsen V; Kvien TK
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1643-5. PubMed ID: 15976829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium and vitamin D preparations in steroid osteoporosis in patients with rheumatoid arthritis].
    Bazhenov AN; Plesovskaia IV; Iliushina LV
    Ter Arkh; 2007; 79(5):89-92. PubMed ID: 17672084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
    Benucci M; Dolenti S; Saviola G; Manfredi M
    Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucocorticoid-induced osteoporosis].
    Tóth M; Tulassay Z
    Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).
    Nawata H; Soen S; Takayanagi R; Tanaka I; Takaoka K; Fukunaga M; Matsumoto T; Suzuki Y; Tanaka H; Fujiwara S; Miki T; Sagawa A; Nishizawa Y; Seino Y;
    J Bone Miner Metab; 2005; 23(2):105-9. PubMed ID: 15750687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.